GlassScriptPhysician profile
Tracia West
NPI 1306251467
$1,907.76
in general payments reported to CMS, 2019-2025
28 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2020: $132 · 2021: $283 · 2022: $324 · 2023: $260 · 2024: $162 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $726.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $463.65 | 2019-2024 | Lo Loestrin Fe |
| Astellas Pharma US INC | $207.67 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $184.60 | 2019-2023 | |
| Amgen INC. | $158.83 | 2019-2025 | Evenity |
| Sumitomo Pharma America, INC. | $135.31 | 2023-2025 | Myfembree, Gemtesa |
| Biogen, INC. | $90.73 | 2024-2025 | Zurzuvae |
| Medtronic, INC. | $68.06 | 2021 | |
| Allergan, INC. | $67.11 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.21 | 2019-2023 | |
| Coopersurgical, INC. | $41.70 | 2021-2024 | Paragard T 380a |
| Avion Pharmaceuticals | $39.85 | 2020-2022 | |
| Hologic Sales and Service, LLC | $38.45 | 2023-2025 | Myosure Tissue Removal Device, Acessa Provu System, Coolseal Generator |
| Millicent US INC | $37.25 | 2024-2025 | Femring, Intrarosa, Femlyv |
| Amag Pharmaceuticals, INC. | $30.98 | 2019 | |
| Ferring Pharmaceuticals INC. | $30.39 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $29.41 | 2025 | Nexplanon, Jada System |
| Mayne Pharma Commercial LLC | $29.37 | 2023-2025 | |
| Exeltis, USA INC. | $28.14 | 2022-2025 | Slynd |
| Therapeuticsmd, INC. | $27.08 | 2022 | |
| Davol INC. | $21.77 | 2021 | |
| Scynexis, INC. | $18.35 | 2022 | |
| Agile Therapeutics, INC. | $17.42 | 2023 | Twirla |
| Boston Scientific Corporation | $17.36 | 2024 | Advantage System |
| Minerva Surgical, INC | $14.02 | 2019 | |
| Merck Sharp & Dohme LLC | $13.48 | 2019 | |
| Intuitive Surgical, INC. | $13.20 | 2020 | |
| Urovant Sciences INC | $13.03 | 2022 | |
| Bsn Medical INC | $12.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracia West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.